期刊文献+

LC-MS/MS同时测定人血浆中阿莫西林-氨溴索浓度及其药动学研究 被引量:3

Simultaneous Determination of Amoxicillin/Ambroxol in Human Plasma by LC-MS/MS and Pharmacokinetic Study
原文传递
导出
摘要 目的建立LC-MS/MS同时测定人血浆中阿莫西林/氨溴索浓度。方法以Lichrospher C18(4.6mm×150mm,5μm)为色谱柱,流动相为甲醇溶液(含0.2%甲酸)和水溶液(含0.2%甲酸),采用梯度洗脱进行分析,流速为1.0mL·min-1,柱温为30℃。血浆样品经甲醇沉淀后进样,采用多反应监测(MRM)方式对样品进行测定。结果血浆中阿莫西林线性范围为5~20000μg·L-1,氨溴索线性范围为1~200μg·L-1;批间和批内精密度RSD均小于9%;方法的准确度为(100±7)%;最低定量限浓度(LLOQ)阿莫西林为5μg·L-1,氨溴索为1μg·L-1。结论本试验建立了同时测定阿莫西林和氨溴索浓度的方法,该方法灵敏、准确、简便、快速,适用于阿莫西林/氨溴索人体药动学研究。 OBJECTIVE To develop a LC-MS/MS method for simultaneous determination of amoxicillin and ambroxol in human plasma. METHODS The Lichrospher C18 column (4.6 mm × 150 mm, 5 pm) was used. The mobile phase consisted of methanol (containing 0.2% formic acid) and 0.2% formic acid water using the gradient program pumped at a flow rate of 1.0 mL.minl at 30 ℃. Plasma samples were loaded after methanol precipitation and analyzed with MRM method. RESULTS Calibration curves were linear in the concentration range of 5-20 000 μg·L^-1 for amoxicillin and 1-200 μg·L^-1 for ambroxol. Both of the intra- and inter- run precisions were less than 9% and the accuracy was (100±7)%. The LLOQs of amoxicillin and ambroxol were determined as 5.0 and 1.0 μg·L^-1, respectively. CONCLUSION The established method was sensitive, accurate, simple and rapid for simultaneous determination of the concentrations of amoxicillin and ambroxol, which was applicable to the clinical monitoring and pharmacokinetic studies.
出处 《中国药学杂志》 CAS CSCD 北大核心 2009年第14期1092-1096,共5页 Chinese Pharmaceutical Journal
关键词 阿莫西林 氨溴索 克伦特罗 药动学 高效液相色谱-质谱联用 amoxicillin ambroxol clenbuterol pharmacokinetics LC-MS/MS
  • 相关文献

参考文献8

  • 1TABISH H, LEANNE M F, SHAMIM A Q, et al. Ambulatory short-course high-dose amoxicillin for treatment of severe pneum in children: a randomised equival trial [J]. Lancet, 2008, 371 (9606): 49-56.
  • 2PETER B. The clinical development and launch of amoxicillin/clavulanate for the treatment of a range of community-acquired infections [J]. Int J Antimicrob, 2007, 30($2): 113-117.
  • 3PAGANIN F, BOUVET O, CHANEZ P, et aL Evaluation oft.he effects of ambroxol on the ofloxacin concentrations in bronchial tissues in COPD patients with infectious exacerbation [J]. Biopharm DrugDispos, 1995, 16(5):393-401.
  • 4WIEMEYER J C. Influence of ambroxol on the bronchopulmonary level of antibiotics [J]. Arzneim-Forsch, 1981, 31 (6): 974-976.
  • 5HWANG M S, CHO S, CHUNG H, et al. Nondestructive determination of the ambroxol content in tablets by Raman spectxoscopy [J]. JPharm Biomed.4nal, 2005, 38(2): 210-215.
  • 6SPATOLA J, PODEROSO J J, WIEMEYER J C, et al. Influence of ambroxol on lung tissue penetration of amoxiciUin [J]. Arzneim-Forsch, 1987, 37(8): 965-966.
  • 7侯芳,张朴,刘燕,李家泰.阿莫西林/克拉维酸钾片在健康人体的药代动力学与药效学[J].中国临床药理学杂志,2006,22(1):40-43. 被引量:19
  • 8QI M L, WANG P, CONG R H, et al. Simultaneous determination of roxithromycin and ambroxol hydrochloride in a new tablet formation by liquid chromatography [J]. J Pharm Biomed Anal, 2004, 35(5): 1287-1291.

二级参考文献13

  • 1卓海通,储小曼,周燕,周洁,曹文.阿莫西林和克拉维酸钾复合制剂的药物动力学[J].中国医院药学杂志,1996,16(5):197-199. 被引量:10
  • 2Craig WA.The future-can we learn from the past[ J] ? Diagn Micro -biol Infect Dis,1997 ;27:49 -53.
  • 3Cars O.Efficacy of beta-lactam antibiotics:integration of pharmacokinetics and pharmacodynamics[ J].Diagn Microbiol Infect Dis,1997;27:29-33.
  • 4Craig WA.Antimicrobial resistant issues of the future[J].Diagn Microbial Infect Dis,1996 ;25:213-217.
  • 5Woodnutt G,Berry V.Two pharmacodynamic models for assessing the efficacy of amoxicillin-clavulanate against experimental respiratory tract infections caused by strains of Streptococcus pneumoniae[ J].Antimicrob Agents Chemother,1999 ;43:29-34.
  • 6Drusano GL,Craig WA.Relevance of pharmacokinetics and pharmaco-dynamics in the selection of antibiotics for respiratory tract infections[J].J Chemother,1997; 9:38 -44.
  • 7Schentag JJ.Antimicrobial action and pharmacokinetics/ pharmacody-namics:the use of AUIC to improve efficacy and avoid resistance[J].J Chemother,1999; 11:426-439.
  • 8Craig WA.Choosing an antibiotic on the basis of pharmacodynamics[J].Ear Nose Throat J,1998 ;77:7-11.
  • 9Escudero E,Carceles XM,Vicente S.Pharmacokinetics of amoxicillin/clavulanic acid combination and of both drugs alone after intravenous administration to goats[ J].Br Vet J,1996; 152:551-559.
  • 10Mark F,Christopher R.Assay of amoxicillin and clavulanic acid,the components of augmentin in biological fluids with high performance liquid chromatography[ J].Antimicrob Agents Chemother,1982 ;22:753-756.

共引文献18

同被引文献524

引证文献3

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部